Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma
Status:
Recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the efficacy of Toripalimab Combined with GP Regimen
Chemotherapy Versus GP Regimen Chemotherapy for Primary Metastatic NPC.
Phase:
Phase 2
Details
Lead Sponsor:
Fudan University
Collaborators:
Affiliated Cancer Hospital & Institute of Guangzhou Medical University Anhui Provincial Hospital Cancer Hospital of Chinese Academy of Medical Science, Shenzhen Center First Affiliated Hospital of Xi'anJiaotong Univerisity Fudan University Eye and ENT Hospital Guangzhou Panyu Central Hospital Hangzhou Cancer Hospital Nanfang Hospital of Southern Medical University Ningbo Medical Center Lihuili Hospital Shenzhen People's Hospital Sir Run Run Shaw Hospital The First People's Hospital of Changzhou